Line 1: | Line 1: | ||
− | <html lang="en | + | <html lang="en"> |
− | + | <head> | |
− | + | <meta charset="utf-8"> | |
− | + | <title>Team:UST_Beijing/Experiments</title> | |
− | + | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | |
− | + | <meta name="description" content=""> | |
− | + | <meta name="author" content=""> | |
− | + | <link href='http://fonts.useso.com/css?family=Lato:400,700,300' rel='stylesheet' type='text/css'> | |
− | + | <!--[if IE]> | |
− | + | <link href="http://fonts.useso.com/css?family=Lato" rel="stylesheet" type="text/css"> | |
− | + | <link href="http://fonts.useso.com/css?family=Lato:400" rel="stylesheet" type="text/css"> | |
− | + | <link href="http://fonts.useso.com/css?family=Lato:700" rel="stylesheet" type="text/css"> | |
− | + | <link href="http://fonts.useso.com/css?family=Lato:300" rel="stylesheet" type="text/css"> | |
− | + | <![endif]--> | |
− | + | <link href="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/css/bootstrap&action=raw&ctype=text/css" rel="stylesheet"> | |
− | + | <link href="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/css/font-awesome&action=raw&ctype=text/css" rel="stylesheet"> | |
− | + | <link href="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/css/theme&action=raw&ctype=text/css" rel="stylesheet"> | |
− | + | <link href="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/css/prettyphoto&action=raw&ctype=text/css" rel="stylesheet" type="text/css"/> | |
− | + | <link href="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/css/zocial&action=raw&ctype=text/css" rel="stylesheet" type="text/css"/> | |
− | + | <link href="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/css/neverslider&action=raw&ctype=text/css" rel="stylesheet" > | |
− | + | ||
− | + | <!--[if lt IE 9]> | |
− | + | <script src="http://apps.bdimg.com/libs/html5shiv/3.7/html5shiv.min.js"></script> | |
− | + | <![endif]--> | |
− | + | </head> | |
− | + | ||
− | + | <body> | |
− | + | <!--header--> | |
− | + | <div class="header"> | |
− | + | <div class="container"> | |
− | + | <!--logo--> | |
− | + | <button type="button" class="btn btn-navbar" data-toggle="collapse" data-target=".nav-collapse"> <i class="fa fa-bars"></i></button> | |
− | + | <div class="logo"> <a href=""><img src="https://static.igem.org/mediawiki/2018/8/8d/T--UST_Beijing--Web_small_logo_USTB.png" width="60" height="60" alt="" class="animated bounceInDown" /></a> </div> | |
− | + | <!--menu--> | |
− | + | <nav id="main_menu"> | |
− | + | <div class="nav-collapse collapse"> | |
− | + | <ul class="nav nav-pills"> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing">Home</a ></li> | |
− | + | <ul class="dropdown-menu"> | |
− | + | </ul> | |
− | + | <li class="dropdown"><a href="javascript:{}">Team</a > | |
− | + | <ul class="dropdown-menu"> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Team">Team member</a ></li> | |
− | + | </ul> | |
− | + | </li> | |
− | + | <li class="dropdown"><a href="javascript:{}">Project</a > | |
− | + | <ul class="dropdown-menu"> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Background">Background</a ></li> | |
− | + | <li><a href="https://static.igem.org/mediawiki/2018/e/e9/T--UST_Beijing--experiment.pdf">Experiments</a ></li> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Notebook">Notebook</a ></li> | |
− | + | </ul> | |
− | + | </li> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Model">Model</a ></li> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Parts">Parts</a ></li> | |
− | + | <li><a href="https://2018.igem.org/Safety/Final_Safety_Form?team_id=2537">Safety</a ></li> | |
− | + | <li class="dropdown"><a href="javascript:{}">Awards</a > | |
− | + | <ul class="dropdown-menu"> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Attributions">Attribution</a ></li> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Collaborations">Collaboration</a ></li> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/InterLab">InterLab</a ></li> | |
− | + | <li><a href="https://2018.igem.org/Team:UST_Beijing/Human_Practices">HumanPractice</a ></li> | |
− | + | </ul> | |
− | + | </li> | |
− | + | </ul> | |
− | + | </div> | |
− | + | </nav> | |
− | + | </div> | |
− | + | </div> | |
− | + | <!--//header--> | |
− | + | <!--page--> | |
− | + | <!--banner--> | |
− | + | <div id="banner"> | |
− | + | <div class="container intro_wrapper"> | |
− | + | <div class="inner_content"> | |
− | + | <div class="pad20"></div> | |
− | + | <div class="row"> | |
− | + | <h1 class="title">Experiments</h1> | |
− | + | <h1><span>Our long-term goal is to improve the health-promoting effects of ginsenosides. We believe that sterols in the ginsenosides are responsible for their main benefits. <br> Therefore in the past projects we engineered synthetic squalene cyclase for in situ production of ginseno-sterols in human cells; and produced synthetic β-glucosidase in E.coli for removal of sugar from ginsenosides.<br> In the current strategy, in the wake of “No release” policy of iGEM community, we are able to by-pass synthetic biology methods to achieve our goal by applying in vitro chemical reactions. </span></h1> | |
− | + | <a href="https://static.igem.org/mediawiki/2018/a/a5/T--UST_Beijing--ep.pdf" class="btn btn-info btn-large btn-rounded">CLICK FOR PDF</a> </div> | |
− | + | </div> | |
− | + | </div> | |
− | + | </div> | |
− | + | <section style="background-image:url(https://static.igem.org/mediawiki/2018/9/95/T--UST_Beijing--ep12.png);background-position:center center;background-repeat:no-repeat;-moz-background-size: cover;background-size: cover;background-attachment:fixed;"> | |
− | + | <div class="container intro_wrapper"> | |
− | + | <div class="inner_content"> | |
− | + | <div class="pad20"></div> | |
− | + | <div class="row"> | |
− | + | <blockquote> | |
− | + | <p>Ginseng products offer unique opportunity to meet the atherosclerosis challenge. Herb catalogs: Ginseng, Western Ginseng, Notoginseng, Jiaogulan etc. | |
− | + | Current herb preparation and administration practice results in poor absorption profile, limits its efficacy and cost-effectiveness. | |
− | + | Since the ginseno-sterols are responsible for their main pharmacological effects, how to achieve effective concentration of sterol in the human body become critical. | |
− | + | </p> | |
− | + | </blockquote> | |
− | + | <blockquote> | |
− | + | <p>In the past, two approaches have been tried to achieve this: (1) Synthesize ginseno-sterols in situ Pro: no need to plant ginseng and harvest, continuous supply of ginseno-sterols; Con: interference with physiology, lack of control in production. (2) Produce beta-glucosides in the gut micro-organism. Pro: convenient to hydrolyze ginsenosides in the gut; Con: interference with gut physiology and probiotics.<br>In the current third approach, we use chemical reaction to hydrolyze the conjugated sugars, to satisfy “No-release” policy if iGEM safety requirement.</p> | |
− | + | </blockquote> | |
− | + | <div class="span4"> | |
− | + | <img src="https://static.igem.org/mediawiki/2018/0/05/T--UST_Beijing--ep13.png" alt=""></div> | |
− | + | <div class="span4"><blockquote><p>A synthetic beta-glucosidase gene is introduced into E.coli, along with PNPG as illustrated below. The enzyme (3D structure is displayed on the left) will make a yellow color product in the medium, which is measured by spectrometry</p></blockquote></div> | |
− | + | <div class="span4" ><img src="https://static.igem.org/mediawiki/2018/3/32/T--UST_Beijing--ep14.png" heigth="70%" alt=""></div> | |
− | + | <h2 class="title">1. Thin—layer chromatography(TLC)</h2> | |
− | + | <h3>Experimental purpose: Through contrast experiments of different method, find out the optimum condition of developing agent ratio in TLC system | |
− | + | <br>Standarded sample: Rb1, Re1, Rg1 10mg/ml<br>After many preliminary experiments, we try to find out a general range of proportion. Here is the last TLC experiment.</h3> | |
− | + | <img src="https://static.igem.org/mediawiki/2018/e/e0/T--UST_Beijing--ep16.png" alt=""> | |
− | + | <h3>chromogenic agent: concentrated sulfuric acid: carbinol = 1:9<br> | |
− | + | standarded sample: extract ginsenosides from traditional Chinese medicine with saturated n-butanol<br> | |
− | + | Result: after change the ratio of chromogenic agent,the experimental phenomenon is much more clear for observing and measuring. | |
− | </div> | + | </h3> |
+ | <h3>Change the developing agent ratio(see table below)</h3> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/0/0c/T--UST_Beijing--ep17.png" alt=""> | ||
+ | <h3>Result: it turns out when the ratio of developing agent is 10:2.5:0.25 and the ratio of chromogenic agent is 9:1,the number of Rf is relatively ideal.</h3> | ||
+ | <h2 class="title">2. A synthetic beta-glucosidase gene is introduced into E.coli, along with PNPG as illustrated below. The enzyme (3D structure is displayed on the left) will make a yellow color product in the medium, which is measured by spectrometry.</h2> | ||
+ | <div class="span3"></div><img src="https://static.igem.org/mediawiki/2018/1/1c/T--UST_Beijing--ep15.png" alt=""> | ||
+ | <h3><span>Experiment assignment:</span><br> | ||
+ | We set three different concentrations of PNPG in 2.5%, 5%, 10% and chose ten different germs (including germ 1 without plasmids) to examine their OD (optional density) by spectrometer once hour.<br> | ||
+ | <span>Specific experimental scheme:</span><br> | ||
+ | Plate E.coli (empty, without Beta glycosidase plasmid) and transformed E.coli on solid medium and culture overnight to obtain monoclonal bacteria and repeat the latter for three times.(temperature:37℃)<br> | ||
+ | Pick the monoclonal bacteria to 2ml liquid LB medium and culture overnight.(temperature:37℃)<br> | ||
+ | Isolate E.coli(BL21-β) from 2 ml LB culture and grow E.coli(BL21-β) in M9 culture for four to six hours.(temperature:37℃)Repeat it for several times.<br> | ||
+ | Use PNPG to verify whether E.coli is modified by Beta glycosidase plasmid.Put samples(including E.coli without Beta glycosidase plasmid) at three different concentrations of 5,10,20% in a 96-well plate by micropipet.<br> | ||
+ | Use ultraviolet spectrophotometer to measure OD value every other hour for 6 times to test whether the plasmid in E. coli was expressed. The color is getting yellow visibly. | ||
+ | </h3> | ||
+ | <h3><span>Initial data:</span></h3> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/0/06/T--UST_Beijing--ep18.png" alt=""> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/4/4c/T--UST_Beijing--ep20.png" alt=""> | ||
+ | <h3><span>Time-dependent production of hydrolzyed color product by beta-glucosidase under different culture conditions:</span></h3> | ||
+ | <div class="span2"></div><img src="https://static.igem.org/mediawiki/2018/0/06/T--UST_Beijing--ep21.png" alt=""> | ||
+ | <h3>As you can see from the above picture, the trend of data curve continues <span>upward</span>. That is to say, PNPG is decomposed,which confirms plasmids are positively transferred.</h3> | ||
+ | <h2 class="title">3. Use chemical method to hydrolyze ginsenoside.</h2> | ||
+ | <div class="span6"> | ||
+ | <h3>Chemical hydrolysis of have been well studied and widely reported in the past. Methods include hydrochloric acid, sodium hydroxide, lactic acid, acidic amino acids, acetic acid, etc. The published methods could generate partial hydrolyzed ginsenosides. Strong acid hydrolyzation results in modification of sterol side chains, as exemplified in the following.</h3> | ||
+ | <img src="https://static.igem.org/mediawiki/2018/d/d8/T--UST_Beijing--ep001.png" alt=""> | ||
</div> | </div> | ||
− | + | <div class="span6"> | |
− | + | <h3>In the current approach, we used a combination of water, butanol, and acetic acid with a proprietary ratio to the ginsenoside substrate mixture to perform the hydrolysis:</h3> | |
− | + | <div class="pad30"></div> | |
− | + | <img src="https://static.igem.org/mediawiki/2018/3/3f/T--UST_Beijing--ep002.png" alt=""> | |
− | + | <img src="https://static.igem.org/mediawiki/2018/3/3f/T--UST_Beijing--ep002.png" alt=""> | |
− | + | ||
− | + | ||
− | < | + | |
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
− | + | <h3><span>Experimental procedure: </span></h3> | |
− | + | <h3>①use different hydrolysis system to hydrolyze ginsenosides. <br> | |
− | + | ②Separate hydrolyzed ginsenosides by standarded TLC system. <br> | |
− | + | ③utilize Double Gene report Test system built in Laboratory to test the bioactivity of hydrolyzed ginsenosides. | |
− | + | </h3> | |
− | + | <div class="span3"></div><img src="https://static.igem.org/mediawiki/2018/3/3f/T--UST_Beijing--ep003.png" alt=""> | |
− | + | <h2 class="title">Discussion:</h2> | |
− | < | + | <h3>Through the chart, we can see that the hydrolyzed ginsenosides has better LXR expression intensity compared to unhydrolyzed LXR expression intensity as density arises. Meanwhile, the effect of hydrolyzed ginsenosides is relatively closed to positive contrast. That is to say, we demonstrate that our natural-re-lease’s method is valid.</h3> |
− | + | </div> | |
− | + | </div> | |
− | + | </div> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | < | + | |
− | < | + | |
− | < | + | |
− | < | + | |
− | < | + | |
− | <!--slider--> | + | |
− | <script src="js/jquery. | + | <!--footer--> |
+ | <div id="footer2"> | ||
+ | <div class="container"> | ||
+ | <div class="row"> | ||
+ | <div class="span12"> | ||
+ | <div class="copyright"> UST_Beijing | ||
+ | © | ||
+ | <script type="text/javascript"> | ||
+ | //<![CDATA[ | ||
+ | var d = new Date() | ||
+ | document.write(d.getFullYear()) | ||
+ | //]]> | ||
+ | </script> | ||
+ | .igem.org </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | </div> | ||
+ | <!-- up to top --> | ||
+ | <a href="#"><i class="go-top hidden-phone hidden-tablet fa-fa-angle-double-up"></i></a> | ||
+ | <!--//end--> | ||
+ | |||
+ | <!-- scripts --> | ||
+ | <script src="http://apps.bdimg.com/libs/jquery/1.9.1/jquery.min.js"></script> | ||
+ | <script src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/jquerytouchswipe&action=raw&ctype=text/javascript"></script> | ||
+ | <script src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/jquerymousewheel&action=raw&ctype=text/javascript"></script> | ||
+ | <script src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/jquerynivosliderpack&action=raw&ctype=text/javascript"></script> | ||
+ | <script src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/bootstrap&action=raw&ctype=text/javascript"></script> | ||
+ | <script type="text/javascript" src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/jqueryprettyphoto&action=raw&ctype=text/javascript"></script> | ||
+ | <script type="text/javascript" src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/scripts&action=raw&ctype=text/javascript"></script> | ||
+ | |||
+ | <!-- slider --> | ||
+ | <script src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/jquery-ui&action=raw&ctype=text/javascript"></script> | ||
+ | <script type="text/javascript" src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/jqueryneverslider&action=raw&ctype=text/javascript"></script> | ||
<script> | <script> | ||
//<![CDATA[ | //<![CDATA[ | ||
− | $(function() { | + | $(document).ready(function() { |
− | $( | + | $(".myslider").show(); |
+ | $(".myslider").startslider({ | ||
+ | sliderWidth:800, | ||
+ | sliderHeight:400, | ||
+ | slideTransitionSpeed: 500, | ||
+ | slideTransitionEasing: "easeOutExpo", | ||
+ | slidesDraggable: true, | ||
+ | sliderResizable: true | ||
+ | }); | ||
+ | }); | ||
+ | //]]> | ||
+ | </script> | ||
+ | |||
+ | <!-- carousel --> | ||
+ | <script type="text/javascript" src="https://2018.igem.org/wiki/index.php?title=Team:UST_Beijing/js/jquerycaroufredsel&action=raw&ctype=text/javascript"></script> | ||
+ | <script type="text/javascript"> | ||
+ | //<![CDATA[ | ||
+ | jQuery(document).ready(function($) { | ||
+ | var portfolioCarousel = $("#slider_small"); | ||
+ | portfolioCarousel.carouFredSel({ | ||
+ | width : "100%", height : "auto", | ||
+ | circular : false, responsive : true, infinite : false, auto : false, | ||
+ | items : { | ||
+ | width : 231, visible: { min: 1, max:1 } | ||
+ | }, | ||
+ | mousewheel: true, | ||
+ | swipe: { onMouse: true, onTouch: true }, | ||
+ | prev : { button : "#sl-prev3", key : "left" }, | ||
+ | next : { button : "#sl-next3", key : "right" }, | ||
+ | onCreate : function () { | ||
+ | $(window).on('resize', function(){ | ||
+ | portfolioCarousel.parent().add(portfolioCarousel).css('height', portfolioCarousel.children().first().outerHeight() + 'px'); | ||
+ | }).trigger('resize'); | ||
+ | } | ||
}); | }); | ||
+ | }); | ||
//]]> | //]]> | ||
− | </script> | + | </script> |
− | + | ||
</body> | </body> | ||
</html> | </html> |
Revision as of 20:45, 9 October 2018
Ginseng products offer unique opportunity to meet the atherosclerosis challenge. Herb catalogs: Ginseng, Western Ginseng, Notoginseng, Jiaogulan etc. Current herb preparation and administration practice results in poor absorption profile, limits its efficacy and cost-effectiveness. Since the ginseno-sterols are responsible for their main pharmacological effects, how to achieve effective concentration of sterol in the human body become critical.
In the past, two approaches have been tried to achieve this: (1) Synthesize ginseno-sterols in situ Pro: no need to plant ginseng and harvest, continuous supply of ginseno-sterols; Con: interference with physiology, lack of control in production. (2) Produce beta-glucosides in the gut micro-organism. Pro: convenient to hydrolyze ginsenosides in the gut; Con: interference with gut physiology and probiotics.
In the current third approach, we use chemical reaction to hydrolyze the conjugated sugars, to satisfy “No-release” policy if iGEM safety requirement.
A synthetic beta-glucosidase gene is introduced into E.coli, along with PNPG as illustrated below. The enzyme (3D structure is displayed on the left) will make a yellow color product in the medium, which is measured by spectrometry